The Galaxy Medicare IPO will open on September 10, 2025, and close on September 12, 2025. The Galaxy Medicare IPO is a book-built issue. The company will raise approximately ₹22.31 crore through the IPO, comprising a fresh issue of ₹17.86 crore and an offer of 8,24,000 equity shares (face value ₹10 per share).
The price band for the Galaxy Medicare IPO is ₹51 to ₹54 per share. The retail quota is 35%, QIB (Qualified Institutional Buyers) 50%, and HNI (High Net Worth Individuals) 15%. The Galaxy Medicare IPO will be listed on the NSE on September 17, 2025. Allotment of shares will take place on September 15, 2025.
The company earned revenue of ₹36.94 crore in 2024, compared to ₹32.03 crore in 2023. The company's profit was ₹3.71 crore in 2024, compared to ₹1.57 crore in 2023. Based on the financial data, the IPO GMP is recommended for long-term investment.
Galaxy Medicare IPO Details
| IPO Open Date | September 10, 2025 |
| IPO Close Date | September 12, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹51 to ₹54 Per Share |
| Issue Size | Approx ₹22.31 Crores |
| Fresh Issue | Approx ₹17.86 Crores |
| Offer for Sale | Approx 8,24,000 Equity Shares |
| Lot Size | 2,000 Shares |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | . |
| RHP Draft Prospectus | . |
Galaxy Medicare IPO Market Lot
The Galaxy Medicare IPO minimum market lot is 4,000 shares with ₹2,16,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 4,000 | ₹2,16,000 |
| Retail Maximum | 2 | 4,000 | ₹2,16,000 |
| S-HNI Minimum | 3 | 6,000 | ₹3,24,000 |
| S-HNI Maximum | 9 | 18,000 | ₹9,72,000 |
| B-HNI Minimum | 10 | 20,000 | ₹10,80,000 |
IPO Reservation
| Investor Category | Share Offered |
| QIB Shares Offered | 50% of the Net Offer |
| NII Shares Offered | 15% of the Net Offer |
| Retail Shares Offered | 35% of the Net Offer |
Galaxy Medicare IPO Anchor Investors
| Anchor Bidding Date | September, 2025 |
| Anchor Investors List | . |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | October, 2025 |
| lock-in period end date 50% shares (90 Days) | December, 2025 |
Galaxy Medicare IPO Dates
The Galaxy Medicare IPO date is September 10 and the close date is September 12. The Galaxy Medicare IPO allotment will be finalized on September 15 and the IPO listing on September 17.
| IPO Open Date: | September 10, 2025 |
| IPO Close Date: | September 12, 2025 |
| Basis of Allotment: | September 15, 2025 |
| Refunds: | September 16, 2025 |
| Credit to Demat Account: | September 16, 2025 |
| IPO Listing Date: | September 17, 2025 |
| IPO Bidding Cut-off Time: | September 12, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Abhiraj Singh Bhal, Raghav Chandra and Varun Khaitan.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,18,63,983 | 89.49% |
| Promoter Holding Post Issue | 1,51,71,983 | 64.60% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores | % |
| Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha | 48.88 | -% |
| Funding the working capital requirements | 99.78 | -% |
| General Corporate Purposes | – | -% |
| To meet the offer related expenses | – | -% |
Galaxy Medicare IPO Company Financial Report
The company reported revenue of ₹36.94 crores in 2024 against ₹32.03 crores in 2023. The company reported profit of ₹3.71 crores in 2024 against profit of ₹1.57 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹30.74 | ₹29.29 | ₹0.21 | ₹30.46 |
| 2023 | ₹32.03 | ₹30.99 | ₹1.57 | ₹32.31 |
| 2024 | ₹36.94 | ₹32.62 | ₹3.71 | ₹32.53 |
| 2025 | ₹17.78 | ₹15.36 | ₹1.71 | ₹31.90 |
Galaxy Medicare IPO Valuation – FY2024
Check Galaxy Medicare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 23.85% |
| ROCE: | 23.80% |
| EBITDA Margin: | 16.91% |
| PAT Margin: | 10.26% |
| Debt to equity ratio: | 0.52 |
| Earning Per Share (EPS): | ₹3.14 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 23.85% |
| Net Asset Value (NAV): | ₹13.10 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Adeshwar Meditex Limited | 1.39 | 17.27 | 2.52% | 24.82 | 0.90 Cr. |
| KMS Medisurgi Limited | 1.38 | 90.58 | 1.02% | 23.41 | 0.08 Cr. |
About the Galaxy Medicare IPO
A leading company, Galaxy Medicare was established in 1992 and is engaged in the manufacturing, selling, and exporting of medical devices, plaster of Paris (POP) bandages, and surgical dressings. With over 30 years of experience in the industry, Galaxy Medicare holds 27 registered trademarks, including popular brands such as POP Band, POP Cast, G-Cast, and CareTape.
By supplying its products to government health departments, large hospitals, and private companies, the company has established a strong and effective presence in India. The company employs approximately 190 people who work on continuous improvement, product innovation, and cost efficiency to meet global standards. Furthermore, with its in-house quality control unit, the company can ensure the design, quality, and finish of its products. All its facilities are equipped with the necessary equipment, machinery, and technology required to manufacture products that meet internationally recognized standards.